Here’s the latest CBD news:
According to the Chicago Sun-Times, CBD pet sales have been on the rise in anticipation of the Fourth of July weekend.
Owners are worried about their frightful pets when the traditional fireworks light up the sky. The frequent explosions can cause anxiety in dogs and cats, and owners are seeking CBD for potential relief.
One pet store, Ruff Haus Pets, tripled orders for CBD pet products to meet demand.
“Dogs are really reacting to fireworks, so [owners are] buying [CBD products] up,” store employee Castor Santee said to Chicago Sun-Times. “We try to keep it in stock as much as possible.”
Sales nearly doubled at Urban Pooch Canine Life Center in Ravenswood, according to operations manager Dylan Feulner.
“We’ve had people coming in this week who have never used CBD products before,” he said. “We’re seeing more customers trying to stay away from prescriptions, looking for something more natural.”
The doctors Chicago Sun-Times spoke to disagree on the use of CBD for dogs, but Dr. David Gonsky, medical director and founder of West Loop Veterinary Care in Chicago, says although the results haven’t been confirmed by science, pet owners have reported that CBD helps to reduce their pets’ stress levels.
“The good news is that well-manufactured CBD by reliable companies is unlikely to cause any harm,” said Dr. Gonsky.
Since not all pets respond well to CBD products, owners are urged to seek out reputable brands.
Senators Dianne Feinstein (D-CA), Chuck Grassley (R-IA), and Brian Schatz (D-HI) introduced an amendment titled “Cannabidiol and Marihuana Research Expansion Act” to be included in the annual renewal of the National Defense Authorization Act.
The amendment aims to promote studies into cannabis and its derivatives, including CBD. It would also allow doctors to discuss marijuana with patients and encourage the development of FDA-approved cannabinoid and marijuana drugs (the latter of which would require DEA approval as well). Lastly, it would make it easier to become a federally-authorized marijuana manufacturer for research or becoming registered to conduct cannabis studies.
Under the bill, the attorney general has a 60-day deadline to approve applications or request additional information from applicants. It would also provide a quicker pathway for researchers to receive larger quantities of Schedule I drugs under approved investigations.
Currently, there is only one cannabis facility that provides material for studies, the quality of which is under question. It’s unclear how the proposed amendment will fare as there are more than 400 amendments filed to the defense spending bill.